Mutant prevention concentration of gemifloxacin for clinical isolates of Streptococcus pneumoniae

被引：42

作者：

Hansen, GT

Metzler, K

Drlica, K

Blondeau, JM ^{[1
]}

机构：

[1] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada

[2] Publ Hlth Res Inst, Newark, NJ 07193 USA

[3] Royal Univ Hosp, Dept Clin Microbiol, Saskatoon, SK S7N 0W8, Canada

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2003年 / 47卷 / 01期

关键词：

D O I：

10.1128/AAC.47.1.440-441.2003

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：440 / 441

页数：2

共 16 条

[11] What have we learned from pharmacokinetic and pharmacodynamic theories? [J].

Schentag, JJ ;

Gilliland, KK ;

Paladino, JA .

CLINICAL INFECTIOUS DISEASES, 2001, 32 :S39-S46

[12] Propensity of fluoroquinolones with different moieties at position 8 to cause resistance development in clinical isolates of Streptococcus pneumoniae [J].

Schmitz, FJ ;

Boos, M ;

Mayer, S ;

Hafner, D ;

Jagusch, H ;

Verhoef, J ;

Fluit, AC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) :2666-2667

[13] Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy [J].

Thomas, JK ;

Forrest, A ;

Bhavnani, SM ;

Hyatt, JM ;

Cheng, A ;

Ballow, CH ;

Schentag, JJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) :521-527

[14] Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy [J].

Urban, C ;

Rahman, N ;

Zhao, XL ;

Mariano, N ;

Segal-Maurer, S ;

Drlica, K ;

Rahal, JJ .

JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (06) :794-798

[15] Restricting the selection of antibiotic-resistant mutants: A general strategy derived from fluoroquinolone studies [J].

Zhao, XL ;

Drlica, K .

CLINICAL INFECTIOUS DISEASES, 2001, 33 :S147-S156

[16] Restricting the selection of antibiotic-resistant mutant bacteria: Measurement and potential use of the mutant selection window [J].

Zhao, XL ;

Drlica, K .

JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (04) :561-565

← 1 2 →